title: The TOSCA.IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes.
authors.forename: Olga
authors.initials: O
authors.lastname: Vaccaro
authors.forename: Maria
authors.initials: M
authors.lastname: Masulli
authors.forename: Enzo
authors.initials: E
authors.lastname: Bonora
authors.forename: Stefano
authors.initials: S
authors.lastname: Del Prato
authors.forename: Antonio
authors.initials: A
authors.lastname: Nicolucci
authors.forename: Angela A
authors.initials: AA
authors.lastname: Rivellese
authors.forename: Gabriele
authors.initials: G
authors.lastname: Riccardi
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D011788:Quality of Life; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D000077205:Pioglitazone